1,8-Dihydroxyanthraquinone
Spécifications
117-10-2Numéro CAS
204-173-5Numéro CE
1,8-dihydroxyanthracene-9,10-dioneNom IUPAC
C14H8O4Formule chimique
240.21 g/molMasse molaire
danthron; 1,8-Dihydroxyanthraquinone; 117-10-2; Dantron; Chrysazin; Dorbane; Istizin; 1,8-Dihydroxyanthracene-9,10-dione; Antrapurol; Diaquone; Altan; Laxanorm; Laxanthreen; Laxipurin; Dionone; Zwitsalax; Danivac; danthrone; 9,10-Anthracenedione, 1,8-dihydroxy-; Dantrone; 1,8-Dihydroxy-9,10-anthraquinone; Dioxyanthrachinonum; Usaf nd-59; 1,8-Dihydroxyanthrachinon; 1,8-Dihydroxy-9,10-anthracenedione; Dantrona; Dantronum; LTAN; 1,8-Dihydroxyanthra-9,10-quinone; 1,4,5,8-Tetroxyantraquinone; Anthraquinone, 1,8-dihydroxy-; DTXSID9020328; Pilules Vinchy N.F.; 1,8-dioxyanthraquinone; NSC7210; Z4XE6IBF3V; NSC-38626; NSC-646568; NSC646568; DTXCID10328; CHEBI:3682; NSC38626; RefChem:585175; A06AB03; 204-173-5; Duolax; Laxipur; Chrysazine; Prugol; Roydan; Dorbanex; Criasazin; 1,8-Dihydroanthraquinone; 1,8-dihydroxy-9,10-dihydroanthracene-9,10-dione; 1,8-dihydroxy-anthraquinone; MFCD00001211; NSC 38626; Dantron [INN]; NSC 646568; 1,8-dihydroxy anthraquinone; CHEMBL53418; Pastomin; Bancon; Istan; component of Doxan; Neokutin S; component of Modane; Scatron D; Dantron (INN); component of Doxidan; component of Dorbantyl; NCGC00091367-01; NCGC00091367-05; 9, 1,8-dihydroxy-; Anthraquinone,8-dihydroxy-; Dantrone [INN-French]; Dantronum [INN-Latin]; Dantrona [INN-Spanish]; WLN: L C666 BV IVJ DQ NQ; 1,8-Dihydroxyanthrachinon [Czech]; Danthron [USP]; CAS-117-10-2; CCRIS 3529; Dithranol EP Impurity B; EINECS 204-173-5; UNII-Z4XE6IBF3V; Istizine; Laxapur; AI3-38117; Chrysazin;; Danthron;; Danivac;; Istizin;; HSDB 7764; 3nsq; Danthron, BAN; Dantron, INN; Danthron (Standard); Dorbanex (Salt/Mix); Dorbantyl (Salt/Mix); Spectrum_001750; dihyanthraquin_P41_LT; DANTHRON [HSDB]; DANTRON [IARC]; DANTHRON [MI]; DANTHRON [VANDF]; 18-Dihydroxyanthraquinone; DANTRON [MART.]; Dantron Impurity Standard; Spectrum2_000603; Spectrum3_000650; Spectrum4_001682; Spectrum5_000324; dihyanthraquin_P21/n_LT; DANTRON [WHO-DD]; NCIMech_000114; dihyanthraquin_P41212_RT; SCHEMBL83688; BSPBio_002259; KBioGR_001944; KBioSS_002230; SPECTRUM211468; 140861-59-2; MLS000069608; Pilules Vinchy N.F. (TN); DivK1c_000284; SPBio_000506; 1,8-DHAQ; MEGxp0_001693; orb1226886; orb1310280; orb3139090; SCHEMBL29356886; SCHEMBL30544826; ACon1_000135; BDBM11316; HMS500O06; HY-B0923R; KBio1_000284; KBio2_002230; KBio2_004798; KBio2_007366; KBio3_001479; NINDS_000284; 1,8-Dihydroxyanthraquinone, 96%; HMS2091A09; HMS3715F08; HMS5083P11; Pharmakon1600-00211468; 8,9-dihydroxy-1,10-anthraquinone; HY-B0923; MSK15523; NSC-7210; Tox21_111122; Tox21_200986; BBL013161; CCG-35470; EBC-26278; NSC755828; s4561; SBB057973; STK238373; AKOS001583216; Tox21_111122_1; 1,8-Dihydroxyanthra-9,10-quinone #; 9,10-Antiraquinone, 1,8-dihydroxy-; CS-4392; DB04816; FD22098; HS-1003; NSC-755828; IDI1_000284; NCGC00091367-02; NCGC00091367-03; NCGC00091367-04; NCGC00091367-06; NCGC00091367-07; NCGC00091367-08; NCGC00258539-01; DA-72552; NCI60_041443; SMR000059018; SY011288; DITHRANOL IMPURITY B [EP IMPURITY]; SBI-0051330.P003; 1,8-Dihydroxy-9,10-anthracenedione, 9CI; D0563; EU-0099935; NS00015698; ST50330603; D07107; F17670; 1,8-Dihydroxyanthracene-9,10-dione (Danthron); AB00051961_09; Danthron (1,8-Dihydroxyanthracene-9,10-dione); EN300-1693514; F540930; SR-01000721864; Q5221244; SR-01000721864-2; BRD-K10065684-001-02-5; BRD-K10065684-001-03-3; BRD-K10065684-001-06-6; BRD-K10065684-001-07-4; 1,8-Dihydroxyanthraquinone, Vetec(TM) reagent grade, 96%; CHZ; InChI=1/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16Synonymes
